CLINICAL_TRIALS trial_result · 2025-02-14

Clinical Trial Update: A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD [Phase 2]

Phase 2 multi-omics disease signature trial in adults with moderate-to-severe Atopic Dermatitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2025-02-14